# An Off-the-Shelf Cell Therapy to Calm Cytokine Storms

Page: https://stenobird.com/podcast/the-bio-report-1092382/an-off-the-shelf-cell-therapy-to-calm-cytokine-storms
Text version: https://stenobird.com/podcast/the-bio-report-1092382/an-off-the-shelf-cell-therapy-to-calm-cytokine-storms.md
Podcast: [The Bio Report](https://stenobird.com/podcast/the-bio-report-1092382)
Published: 2026-04-29T07:00:00+00:00
Episode link: https://thebioreport.podbean.com/e/an-off-the-shelf-cell-therapy-to-calm-cytokine-storms/
Audio file: https://mcdn.podbean.com/mf/web/jzzmmhnim8zgcq46/BR-Silvu_Itescu_-_4-29-26aic8l.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-bio-report-1092382/episodes/an-off-the-shelf-cell-therapy-to-calm-cytokine-storms
Duration seconds: 1709

## Resource

Small molecule drugs and monoclonal antibodies often fall short at addressing severe inflammatory and immune‑mediated diseases. Mesoblast has spent more than 15 years industrializing mesenchymal stromal cell therapies to treat these conditions. In late 2024, it won U.S. Food and Drug Administration approval for Ryoncil, the first mesenchymal stromal cell therapy approved in the United States. Ryoncil is approved to treat steroid‑refractory acute graft‑versus‑host disease in pediatric patients 2 months of age and older. Mesoblast founder and CEO Silviu Itescu discusses how this class of therapy can help dampen cytokine‑driven hyperinflammation, how the company is extending its platform into other high‑burden conditions, and what distinguishes its second‑generation cell therapy now in development from its first.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-bio-report-1092382/episodes/an-off-the-shelf-cell-therapy-to-calm-cytokine-storms/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-bio-report-1092382/an-off-the-shelf-cell-therapy-to-calm-cytokine-storms.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.